2019-09-20
Therapeutics Solutions International, an active company in nanomedicine, is filing a patent application for a drug that employs nanoemulsions to concurrently kill cancer cells and accelerate the recovery of blood cells after treatment with chemotherapy. This nanomedicine protects the bone marrow, stimulates the immune system, and suppresses the growth of cancer.
